Short Interest in Exicure, Inc. (NASDAQ:XCUR) Drops By 17.3%

Exicure, Inc. (NASDAQ:XCUR) saw a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling 50,600 shares, a decline of 17.3% from the December 15th total of 61,200 shares. Based on an average daily volume of 727,200 shares, the short-interest ratio is presently 0.1 days. Currently, 21.5% of the company’s shares are sold short.

Exicure Price Performance

Exicure stock opened at $9.14 on Thursday. Exicure has a 1 year low of $1.44 and a 1 year high of $36.00. The company’s 50 day simple moving average is $14.71 and its 200-day simple moving average is $6.21.

Exicure Company Profile

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.